Androgen-Induced <i>TMPRSS2:ERG</i> Fusion in Nonmalignant Prostate Epithelial Cells
Nuria Coll Bastus(Queen Mary University of London), Yong‐Jie Lu(Queen Mary University of London), Daniel M. Berney(Queen Mary University of London), R.T.D. Oliver(University of Cambridge), Lara K. Boyd(Queen Mary University of London), Xueying Mao(Ministry of Education), Sakunthala C. Kudahetti(Queen Mary University of London), Elzbieta Stankiewicz(Queen Mary University of London)
Cited by 100
Related Papers
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
|The Lancet|2005|447
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
|Journal of Clinical Oncology|1997|334
The World Health Organization 2016 classification of testicular non‐germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
|Histopathology|2016|236
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System
|PLoS ONE|2015|226
The complexity of prostate cancer: genomic alterations and heterogeneity
|Nature Reviews Urology|2012|218